| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/01/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/12/2023 |
SC 13D
| BioImpact Capital LLC reports a 40% stake in REUNION NEUROSCIENCE INC. |
| 05/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/06/2022 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 158,579 shares
@ $42.05, valued at
$6.7M
Sold 32,396 shares
@ $43.2, valued at
$1.4M
Sold 11,318 shares
@ $45.32, valued at
$512.9k
Sold 12,829 shares
@ $46.47, valued at
$596.2k
Sold 30,347 shares
@ $42.03, valued at
$1.3M
|
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 10,952 shares
@ $35.49, valued at
$388.7k
Sold 10,258 shares
@ $36.03, valued at
$369.6k
Sold 16,856 shares
@ $34.46, valued at
$580.9k
Sold 500 shares
@ $35.37, valued at
$17.7k
|
|
| 11/24/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Disposed of 15,671 shares
@ $0
Sold 15,575 shares
@ $37.16, valued at
$578.8k
Sold 19,758 shares
@ $37.81, valued at
$747k
Sold 32,876 shares
@ $36.21, valued at
$1.2M
Sold 600 shares
@ $36.5, valued at
$21.9k
Sold 8,147 shares
@ $35.2, valued at
$286.8k
Sold 30,696 shares
@ $36.05, valued at
$1.1M
Sold 21,965 shares
@ $37.02, valued at
$813.1k
|
|
| 10/18/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 14,882 shares
@ $27.53, valued at
$409.7k
Sold 3,413 shares
@ $28.01, valued at
$95.6k
Sold 10,320 shares
@ $27.14, valued at
$280.1k
|
|
| 10/14/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 14,260 shares
@ $27.09, valued at
$386.3k
Sold 35,023 shares
@ $27.13, valued at
$950.2k
Sold 45,719 shares
@ $27.3, valued at
$1.2M
|
|
| 10/12/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 1,922 shares
@ $27, valued at
$51.9k
Sold 3,400 shares
@ $27.01, valued at
$91.8k
Sold 81,684 shares
@ $27.24, valued at
$2.2M
|
|
| 10/05/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 11,471 shares
@ $27, valued at
$309.7k
Sold 34,659 shares
@ $27.06, valued at
$937.9k
|
|
| 09/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2021 |
4
| UBS Oncology Impact Fund L.P. (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 3,124 shares
@ $29.06, valued at
$90.8k
|
|
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|